Galenica Sante AG (GALE) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Galenica Sante AG (GALE) has a cash flow conversion efficiency ratio of 0.129x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CHF190.83 Million ≈ $241.26 Million USD) by net assets (CHF1.49 Billion ≈ $1.88 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See GALE equity financing ratio to measure how much of total assets are equity-financed.
Galenica Sante AG - Cash Flow Conversion Efficiency Trend (2014–2025)
This chart illustrates how Galenica Sante AG's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Galenica Sante AG cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Galenica Sante AG Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Galenica Sante AG ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Persimmon Plc
F:OHP
|
-0.038x |
|
Caihong Display Devices Co Ltd
SHG:600707
|
0.022x |
|
Jiangsu Guoxin Corp Ltd
SHE:002608
|
0.035x |
|
Monday.Com Ltd
NASDAQ:MNDY
|
0.138x |
|
Shanghai Junshi Biosciences Co Ltd
SHG:688180
|
-0.023x |
|
Guizhou Space Appliance Co Ltd
SHE:002025
|
-0.065x |
|
PBF Energy Inc
NYSE:PBF
|
0.005x |
|
Global Health Limited
NSE:MEDANTA
|
0.082x |
Annual Cash Flow Conversion Efficiency for Galenica Sante AG (2014–2025)
The table below shows the annual cash flow conversion efficiency of Galenica Sante AG from 2014 to 2025. For the full company profile with market capitalisation and key ratios, see Galenica Sante AG stock valuation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CHF1.49 Billion ≈ $1.88 Billion |
CHF299.76 Million ≈ $378.98 Million |
0.202x | +18.34% |
| 2024-12-31 | CHF1.55 Billion ≈ $1.96 Billion |
CHF264.70 Million ≈ $334.66 Million |
0.171x | +11.48% |
| 2023-12-31 | CHF1.48 Billion ≈ $1.87 Billion |
CHF225.71 Million ≈ $285.36 Million |
0.153x | -19.29% |
| 2022-12-31 | CHF1.25 Billion ≈ $1.58 Billion |
CHF236.87 Million ≈ $299.47 Million |
0.190x | -29.79% |
| 2021-12-31 | CHF1.23 Billion ≈ $1.56 Billion |
CHF333.10 Million ≈ $421.12 Million |
0.270x | +26.76% |
| 2020-12-31 | CHF1.05 Billion ≈ $1.33 Billion |
CHF224.36 Million ≈ $283.65 Million |
0.213x | -14.99% |
| 2019-12-31 | CHF999.54 Million ≈ $1.26 Billion |
CHF250.44 Million ≈ $316.62 Million |
0.251x | +34.78% |
| 2018-12-31 | CHF933.60 Million ≈ $1.18 Billion |
CHF173.55 Million ≈ $219.41 Million |
0.186x | +10.91% |
| 2017-12-31 | CHF861.51 Million ≈ $1.09 Billion |
CHF144.40 Million ≈ $182.56 Million |
0.168x | -64.28% |
| 2016-12-31 | CHF334.20 Million ≈ $422.53 Million |
CHF156.82 Million ≈ $198.26 Million |
0.469x | -8.17% |
| 2015-12-31 | CHF259.19 Million ≈ $327.69 Million |
CHF132.44 Million ≈ $167.43 Million |
0.511x | +45.94% |
| 2014-12-31 | CHF240.26 Million ≈ $303.76 Million |
CHF84.12 Million ≈ $106.35 Million |
0.350x | -- |
About Galenica Sante AG
Galenica AG provides healthcare services in Switzerland and internationally. It operates through two segments, Products & Care, and Logistics & IT. The Products & Care segment operates and manages pharmacies and partner pharmacies under the Amavita, Sun Store, and Coop Vitality brands, as well as covers specialty pharmacy mediservice. This segment also offers medication for treatment of patients … Read more